Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.03, read 2026-10-23
Ethical does not pass the values gate
Price10.17 USD
Fair value12.00
Ethical score70.0/100
Our investment reviews on this name
2026-10-27Read Markup9.53+6.7% to today ✓Distribution gives way to Markup first Markup read since July
2026-10-21Read Distribution9.60+5.9% to today Markdown gives way to Distribution after an 18% slide in 8 weeks
2026-08-26Read Markdown11.66-12.8% to today ✓Markup gives way to Markdown after a 5% slide in 8 weeks
2026-07-02Read Markup12.28-17.2% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Douglas Emmett, Inc. holds its Markup at $10.17. The statistical read favours the sellers, held for 1 days.
As held on the ledger · 2026-10-23
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 1 days
Price at the screen
$10.17
Valuation
N/A trailing · -54.36 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.21
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
59.86%
Below 33%
Interest-bearing debt is 59.9% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
3.67%
Below 49%
Money owed to the company is 3.7% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Douglas Emmett,'s business is in a permissible area, but its interest-bearing debt is about 60% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when DEI's ethical verdict changes
Today DEI does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 25.9% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Hold. The average target sits +18% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Prime Coastal Offices Face A Tenant Exodus
Picture a landlord in Santa Monica or Honolulu whose best buildings sit half empty while workers stay home. Douglas Emmett owns exactly those high quality offices and multifamily blocks, yet revenue has flatlined and the company is losing money at every level.
The numbers rule out any case for ownership. Forward earnings sit deep in the red, margins are negative, and return on equity offers no cushion at the current price that matches our fair value exactly. With zero growth and an unknown competitive edge, this is not a bargain but a business showing clear strain.
Office REITs remain cyclical and exposed to lasting shifts in how companies use space. Remote work and economic softness could keep pressure on occupancy and rents for years. Ethical screen cleared, yet the financial picture gives no reason to step in. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
DEI trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Markup$9.53+0.0%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 11%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $12. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markup · changed$9.53-0.7%Entry 9
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 11%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $12. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Distribution · changed$9.60-1.9%Entry 8
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 11%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-10-14Markdown$9.79-6.0%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 11%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-10-02Markdown$10.41-10.7%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 11%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $12. Since the last review it its composite score rose.
2026-08-26Markdown · changed$11.66-6.8%Entry 5
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 11%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-07-26Markup$12.51+1.9%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 11%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-07-18Markup$12.28+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 11%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-07-03Markup$12.28+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$12.28Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
